312 related articles for article (PubMed ID: 10051627)
21. DNA vaccines for influenza virus: differential effects of maternal antibody on immune responses to hemagglutinin and nucleoprotein.
Pertmer TM; Oran AE; Moser JM; Madorin CA; Robinson HL
J Virol; 2000 Sep; 74(17):7787-93. PubMed ID: 10933685
[TBL] [Abstract][Full Text] [Related]
22. Suppression of innate immune pathology by regulatory T cells during Influenza A virus infection of immunodeficient mice.
Antunes I; Kassiotis G
J Virol; 2010 Dec; 84(24):12564-75. PubMed ID: 20943986
[TBL] [Abstract][Full Text] [Related]
23. Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants.
Benne CA; Harmsen M; van der Graaff W; Verheul AF; Snippe H; Kraaijeveld CA
Vaccine; 1997 Jun; 15(9):1039-44. PubMed ID: 9261954
[TBL] [Abstract][Full Text] [Related]
24. CD83 expression regulates antibody production in response to influenza A virus infection.
Akauliya M; Gautam A; Maharjan S; Park BK; Kim J; Kwon HJ
Virol J; 2020 Dec; 17(1):194. PubMed ID: 33302987
[TBL] [Abstract][Full Text] [Related]
25. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
26. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection.
Tamura S; Iwasaki T; Thompson AH; Asanuma H; Chen Z; Suzuki Y; Aizawa C; Kurata T
J Gen Virol; 1998 Feb; 79 ( Pt 2)():291-9. PubMed ID: 9472613
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice.
Wang M; Huang Y; Gu W; Wang H
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658200
[TBL] [Abstract][Full Text] [Related]
28. Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza.
Lund FE; Partida-Sánchez S; Lee BO; Kusser KL; Hartson L; Hogan RJ; Woodland DL; Randall TD
J Immunol; 2002 Nov; 169(9):5236-43. PubMed ID: 12391242
[TBL] [Abstract][Full Text] [Related]
29. Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination.
O E; Lee YT; Ko EJ; Kim KH; Lee YN; Song JM; Kwon YM; Kim MC; Perez DR; Kang SM
J Virol; 2014 Jul; 88(14):7764-75. PubMed ID: 24760891
[TBL] [Abstract][Full Text] [Related]
30. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection.
Baumgarth N; Herman OC; Jager GC; Brown LE; Herzenberg LA; Chen J
J Exp Med; 2000 Jul; 192(2):271-80. PubMed ID: 10899913
[TBL] [Abstract][Full Text] [Related]
31. Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice.
Jayasekera JP; Vinuesa CG; Karupiah G; King NJC
J Gen Virol; 2006 Nov; 87(Pt 11):3361-3371. PubMed ID: 17030871
[TBL] [Abstract][Full Text] [Related]
32. The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.
Keating R; Hertz T; Wehenkel M; Harris TL; Edwards BA; McClaren JL; Brown SA; Surman S; Wilson ZS; Bradley P; Hurwitz J; Chi H; Doherty PC; Thomas PG; McGargill MA
Nat Immunol; 2013 Dec; 14(12):1266-76. PubMed ID: 24141387
[TBL] [Abstract][Full Text] [Related]
33. The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice.
Dobber R; Tielemans M; Nagelkerken L
Cell Immunol; 1995 Feb; 160(2):185-92. PubMed ID: 7720078
[TBL] [Abstract][Full Text] [Related]
34. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production.
Iwasaki T; Nozima T
J Immunol; 1977 Jan; 118(1):256-63. PubMed ID: 401512
[TBL] [Abstract][Full Text] [Related]
35. Influenza virus depresses the PFC response of mice by affecting T-cell function.
Ichikawa K; Miura R
Acta Virol; 1987 May; 31(3):203-17. PubMed ID: 2888284
[TBL] [Abstract][Full Text] [Related]
36. Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection.
Schmitz N; Beerli RR; Bauer M; Jegerlehner A; Dietmeier K; Maudrich M; Pumpens P; Saudan P; Bachmann MF
Eur J Immunol; 2012 Apr; 42(4):863-9. PubMed ID: 22531913
[TBL] [Abstract][Full Text] [Related]
37. Persistence of influenza virus-specific antibody-secreting cells and B-cell memory after primary murine influenza virus infection.
Jones PD; Ada GL
Cell Immunol; 1987 Oct; 109(1):53-64. PubMed ID: 3498544
[TBL] [Abstract][Full Text] [Related]
38. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
Kostolanský F; Mucha V; Slováková R; Varecková E
Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
[TBL] [Abstract][Full Text] [Related]
39. Induction of cytolytic T- and B-cell responses against influenza virus infections.
Armerding D; Rossiter H
Infect Immun; 1980 Jun; 28(3):799-811. PubMed ID: 6967451
[TBL] [Abstract][Full Text] [Related]
40. Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance.
Mozdzanowska K; Maiese K; Gerhard W
J Immunol; 2000 Mar; 164(5):2635-43. PubMed ID: 10679103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
